Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV
Clinical trial NCT01637844 · COMPLETED
Trial details
- NCT number
- NCT01637844
- Sponsor
- Yi-Hua Zhou
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2014-10-01
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.